| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ULTRAGENYX PHARMACEUTICAL INC COM | 160,000 | 11,250,000 | 6.72% | ||
| 2 | BIOGEN INC | 35,000 | 9,925,000 | 5.93% | ||
| 3 | MEDICINES CO | 275,000 | 9,334,000 | 5.58% | ||
| 4 | CELGENE CORP | 80,000 | 9,260,000 | 5.53% | ||
| 5 | AMGEN INC | 50,000 | 7,311,000 | 4.37% | ||
| 6 | ALEXION PHARMACEUTIC | 55,000 | 6,729,000 | 4.02% | ||
| 7 | MERCK & CO INC | 110,000 | 6,476,000 | 3.87% | ||
| 8 | ZIMMER BIOMET HLDGS INC | 50,000 | 5,160,000 | 3.08% | ||
| 9 | NUVASIVE INC COM | 70,000 | 4,715,000 | 2.82% | ||
| 10 | DERMIRA INC | 150,000 | 4,550,000 | 2.72% | ||
| 11 | ABBOTT LABS | 115,000 | 4,417,000 | 2.64% | ||
| 12 | AERIE PHARMACEUTICALS INC | 115,000 | 4,353,000 | 2.60% | ||
| 13 | ONCOMED PHARMACEUTICALS INC | 550,000 | 4,241,000 | 2.53% | ||
| 14 | GLAUKOS CORP | 120,000 | 4,116,000 | 2.46% | ||
| 15 | MAZOR ROBOTICS LTD | 175,000 | 3,836,000 | 2.29% | ||
| 16 | ISHARES TR | 25,000 | 3,371,000 | 2.01% | Put | |
| 17 | CIGNA CORPORATION | 25,000 | 3,335,000 | 1.99% | Call | |
| 18 | CLOVIS ONCOLOGY INC | 75,000 | 3,332,000 | 1.99% | ||
| 19 | MERUS N V | 150,000 | 3,167,000 | 1.89% | ||
| 20 | K2M GROUP HLDGS INC COM | 150,000 | 3,006,000 | 1.80% | ||
| 21 | ALDER BIOPHARMACEUTICALS INC | 140,000 | 2,912,000 | 1.74% | ||
| 22 | WALGREENS BOOTS ALLIANCE INC | 35,000 | 2,897,000 | 1.73% | ||
| 23 | ANTHEM INC | 20,000 | 2,875,000 | 1.72% | ||
| 24 | SPECTRANETICS CORP | 110,000 | 2,695,000 | 1.61% | ||
| 25 | ALLERGAN PLC | 12,500 | 2,625,000 | 1.57% | ||
| 26 | GLOBAL BLOOD THERAPEUTICS IN COM | 175,000 | 2,529,000 | 1.51% | ||
| 27 | SUPERNUS PHARMACEUTICALS INC COM | 100,000 | 2,525,000 | 1.51% | ||
| 28 | HEALTHWAYS INC | 100,000 | 2,275,000 | 1.36% | ||
| 29 | WALGREENS BOOTS ALLIANCE INC | 25,000 | 2,069,000 | 1.24% | Call | |
| 30 | CHEMOCENTRYX INC | 270,000 | 1,998,000 | 1.19% | ||
| 31 | REGENERON PHARMACEUTICALS | 5,001 | 1,836,000 | 1.10% | ||
| 32 | GILEAD SCIENCES INC | 25,000 | 1,790,000 | 1.07% | ||
| 33 | MINERVA NEUROSCIENCES INC COM | 150,000 | 1,763,000 | 1.05% | ||
| 34 | ADVANCED ACCELERATOR APPLIC | 60,000 | 1,606,000 | 0.96% | ||
| 35 | ACCELERON PHARMA | 60,000 | 1,531,000 | 0.92% | ||
| 36 | MYLAN N V | 40,000 | 1,526,000 | 0.91% | ||
| 37 | BOSTON SCIENTIFIC CORP | 65,000 | 1,406,000 | 0.84% | ||
| 38 | LHC GROUP INC COM | 30,000 | 1,371,000 | 0.82% | ||
| 39 | ASTRAZENECA PLC | 50,000 | 1,366,000 | 0.82% | ||
| 40 | AstraZeneca PLC | 50,000 | 1,366,000 | 0.82% | Call | |
| 41 | ACLARIS THERAPEUTICS INC COM | 50,000 | 1,357,000 | 0.81% | ||
| 42 | DEXCOM | 20,000 | 1,194,000 | 0.71% | ||
| 43 | IMMUNOMEDICS INC | 300,000 | 1,101,000 | 0.66% | ||
| 44 | Intersect ENT Inc | 75,000 | 908,000 | 0.54% | ||
| 45 | SPDR SERIES TRUST | 15,000 | 888,000 | 0.53% | Call | |
| 46 | ARRAY BIOPHARMA INC COM | 100,000 | 879,000 | 0.53% | ||
| 47 | HORIZON PHARMA PLC | 50,000 | 809,000 | 0.48% | ||
| 48 | SCYNEXIS INC | 250,000 | 798,000 | 0.48% | ||
| 49 | RA PHARMACEUTICALS INC | 50,000 | 760,000 | 0.45% | ||
| 50 | ACHAOGEN INC COM | 50,000 | 651,000 | 0.39% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001597549-17-000004, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
